Using data science to forecast clinical trial outcomes
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
By
National Capital Protocol Toolkit (NCT) offers companies a structured process to identify key business risks and opportunities in their management of natural resources.
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
By
A free, updated simulator allows users to visualize environmental impacts and better guide climate decision-making in their organizations.